Company Name: Dimension Therapeutics Inc.
Dimension Therapeutics Inc. develops therapeutics for rare diseases associated with the liver. The company has several programs that it is advancing toward clinical development, which include treatment candidates for:
- Glycogen storage disease type Ia (GSDIa)
- Hemophilia A (collaboration with Bayer HealthCare)
- Hemophilia B
- Ornithine transcarbamylase (OTC) deficiency
Ticker Symbol: DMTX (NASDAQ)
Company Website: www.dimensiontx.com
Social Media:
Dimension Therapeutics LinkedIn
Dimension Therapeutics Twitter
Classification: Biotech
Areas of Focus:
Headquarters: Cambridge, MA
Related Links:
List of Pharmaceutical Companies
Publicly Traded Companies in Massachusetts
Publicly Traded Companies by Sector and Industry